Related Articles
Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review)
Amplification of mutant <em>KRAS</em><sup>G12D</sup> in a patient with advanced metastatic pancreatic adenocarcinoma detected by liquid biopsy: A case report
c‑Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer
Alisertib exerts KRAS allele‑specific anticancer effects on colorectal cancer cell lines
MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway Retraction in /10.3892/or.2022.8424